Search

Your search keyword '"Francis J. Hornicek"' showing total 268 results

Search Constraints

Start Over You searched for: Author "Francis J. Hornicek" Remove constraint Author: "Francis J. Hornicek" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
268 results on '"Francis J. Hornicek"'

Search Results

1. Imaging-Based Disease Assessment and Management Recommendations: Impact of Multidisciplinary Sarcoma Tumor Board

2. Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients

3. Expression of Concern: T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma

4. In situ hybridization to detect DNA amplification in extracellular vesicles

5. Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcoma

6. The role of extracelluar matrix in osteosarcoma progression and metastasis

7. Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2

8. Exosomes promote pre-metastatic niche formation in ovarian cancer

9. Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcomaResearch in context

11. ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer

12. Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study

13. Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma

15. CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells

16. Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma

17. Advances in immune checkpoint inhibitors for bone sarcoma therapy

18. Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution

19. The Discrepancy between Patient and Clinician Reported Function in Extremity Bone Metastases

20. Characteristics and Patterns of Metastatic Disease from Chordoma

21. Rhabdomyosarcoma: Advances in Molecular and Cellular Biology

22. The Use of Radiation Therapy in the Management of Selected Patients with Atypical Lipomas

23. MicroRNA Involvement in Osteosarcoma

25. Data from Cyclin G–Associated Kinase Is Necessary for Osteosarcoma Cell Proliferation and Receptor Trafficking

26. Supplementary Figure 1 from Programmed Cell Death Ligand 1 Expression in Osteosarcoma

29. Expression and Clinical Significance of High‐Mobility Group <scp>AT‐hook 2</scp> ( <scp>HMGA2</scp> ) in Osteosarcoma

31. Data from Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines

33. Supplementary Fig. S1 from Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer

34. Data from Expression and Therapeutic Potential of SOX9 in Chordoma

36. Data from Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer

39. Supplementary Data from Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines

41. Figure S1-2 from Expression and Therapeutic Potential of SOX9 in Chordoma

43. Data from Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation

45. Distal femoral replacement – Cemented or cementless? Current concepts and review of the literature

46. T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma

47. Personalized chordoma organoids for drug discovery studies

48. SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma

49. MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma

50. The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma

Catalog

Books, media, physical & digital resources